Provided by Tiger Trade Technology Pte. Ltd.

MannKind

3.95
+0.05001.28%
Post-market: 3.90-0.0500-1.27%19:30 EDT
Volume:10.19M
Turnover:40.82M
Market Cap:1.27B
PE:-28.21
High:4.23
Open:3.84
Low:3.83
Close:3.90
52wk High:6.51
52wk Low:2.23
Shares:321.54M
Float Shares:309.97M
Volume Ratio:1.63
T/O Rate:3.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1400
EPS(LYR):0.0200
ROE:32.74%
ROA:0.79%
PB:-18.90
PE(LYR):197.50

Loading ...

MannKind Shareholders Reaffirm Board, Pay, and Auditor Roles

TIPRANKS
·
May 23

MannKind shareholders elect nine directors at annual meeting

Reuters
·
May 23

MannKind EVP, General Counsel David Thomson disposes 15,420 shares worth $53,624.52

Reuters
·
May 14

MannKind director Steven B. Binder disposes of 22,500 shares worth $75,927.40

Reuters
·
May 14

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

MannKind price target lowered to $7 from $8 at Mizuho

TIPRANKS
·
May 07

MannKind Corp Shares Marginally Down After Co Swings to Net Loss

THOMSON REUTERS
·
May 07

BUZZ-MannKind falls after quarterly revenue miss

Reuters
·
May 07

MannKind Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

Stock Track | MannKind Plunges 11.13% in Pre-Market After Q1 Earnings Miss and Swing to Loss

Stock Track
·
May 07

Stock Track | MannKind Plunges 9.27% Intraday After Q1 Earnings Miss and Swing to Net Loss

Stock Track
·
May 07

MannKind reports Q1 EPS (2c), consensus 1c

TIPRANKS
·
May 07

MannKind Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

MannKind Q1 revenue rises 15% but swings to net loss

Reuters
·
May 07

MannKind Q1 Adj. EPS $(0.02) Misses $(0.00) Estimate, Sales $90.171M Miss $106.555M Estimate

Benzinga Earnings
·
May 07

MannKind Q1 FY26 swings to net loss of $16.62 million; revenue rises 15% to $90.17 million

Reuters
·
May 07

BRIEF-MannKind Q1 Pretax Profit USD -16.366 Million

Reuters
·
May 07

MannKind Q1 Basic EPS USD -0.05

THOMSON REUTERS
·
May 07

MannKind Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 07

MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged

TIPRANKS
·
May 07